Clicky

Sansure Biotech Inc(688289)

Description: Sansure Biotech Inc. engages in the research and development, production, and sale of in-vitro diagnostic reagents and ancillary instruments in China. The company offers Hepatitis B virus nucleic acid detection kits, fully automatic nucleic acid extraction system, real-time fluorescent quantitative PCR analysis system, fully automatic cup and liquid processing system, mobile molecular diagnostic system, and high-throughput sequencing system. It also provides genetic testing services; next generation sequencing services; bioinformatics analysis services; and postdoctoral recruitment and scientific research cooperation services, as well as third-party medical testing services. The company was founded in 2008 and is headquartered in Changsha, China.


Keywords: Natural Sciences Biotechnology Biology Molecular Biology Hepatitis B Laboratory Techniques Bioinformatics Polymerase Chain Reaction DNA Sequencing Amplifiers Genetic Testing Services Generation Sequencing Services Medical Testing Services Nucleic Acid Methods

Home Page: www.sansure.com.cn

No. 680, Lusong Road
Changsha, 410205
China
Phone: 86 73 1888 8317


Officers

Name Title
Mr. Lizhong Dai Chairman & GM
Mr. Peng Zhu CFO, Deputy GM, Board Sec. & Director
Mr. Xialin Yu Deputy GM & Director
Mr. Xu Fan Deputy GM & Director
Ms. Jun Zhou Deputy GM & Chief Medical Officer
Mr. Yanhuan Wan Deputy Gen. Mang.
Mr. Jia Liu Deputy Gen. Mang.
Mr. Liu Kai Deputy Gen. Mang.
Mr. Jian Zhu Deputy Gen. Mang.

Exchange: SHG

Country: CN

Currency: Renminbi (¥)

Forward PE: 0
Trailing PE: 6.3559
Price-to-Book MRQ: 1.846
Price-to-Sales TTM: 2.6946
IPO Date:
Fiscal Year End: December
Full Time Employees: 1729
Back to stocks